Gene Query: TSSC4

Dataset Description Geneva Score
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 37.96
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 18.36
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 14.68
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 14.68
The landscape of alternative splicing in aggressive prostate cancers 14.42
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 13.9
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 13.08
Effect of mitochondria deficiency on senescence-associated gene expression 12.98
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 12.83
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 11.7
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 11.47
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 11.08
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 10.44
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 10.42
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 9.96
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 9.37
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 9.37
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.09
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 9.08
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 9.06
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 8.83
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 8.47
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.19
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 8.1
LncRNA expression profiling of ischemic stroke patients 7.93
Small-molecule targeting of brachyury transcription factor addiction in chordoma 7.67
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 7.66
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 7.65
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.59
Neonatal and adult human testis defined at the single-cell level 7.56
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 7.51
DART-seq: an antibody-free method for global m6A detection 7.48
U1 snRNP telescripting regulates size-function stratified human genome 7.48
Co-transcriptional loading of RNA export factors shapes the human transcriptome 7.44
RNAseq of HEK293 cells after Chtop knockdown 7.44
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 7.37
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.21
Differential gene expression of human melanoma cells [RNA-seq] 7.21
Stem and effector CD8 T-cells from human cancers 7.11
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 7.09
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.91
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 6.82
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 6.7
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 6.7
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 6.69
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 6.68
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 6.66
Survival of pancreatic cancer cells lacking KRAS function 6.4
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 6.21
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.2
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 6.18
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 6.16
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.13
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 6.12
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 6.07
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.85
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.76
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.73
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 5.51
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 5.5
The comparison of high-throughput single-cell RNA-seq methods 5.45
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 5.42
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 5.35
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 5.34
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.29
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.29
RNA-seq in transgenic cells 5.29
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 5.25
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.24
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 5.17
High-Throughput Kinetic Analysis of Fractional Killing 5.14
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 5.13
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.05
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.97
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 4.97
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.96
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 4.93
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 4.92
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.91
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 4.88
Generation and persistence of human tissue-resident memory T cells in lung transplantation 4.83
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.81
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 4.75
Transcriptome analysis of SKI knock-out in HL60 cells 4.72
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 4.72
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.72
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.72
The regulartory role of ZCCHC24 in splicing machinery 4.71
AUF-1 affected genes in human skin cells 4.7
Identification of a LIF-responsive replication-competent human β cell 4.69
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 4.65
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 4.65
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 4.63
RNAseq Study in CC-671 Treated Cal-51 Cells 4.55
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.54
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.48
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.47
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.46
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 4.46
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 4.42
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.41
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.41
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.4
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.4
Effect of from Human Umbilical Vein Endothelial Cells 4.37
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.36
Endothelial gene expression analysis 4.26
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 4.26
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.25
RNA-seq analysis upon ARID1B overexpression 4.23
Capturing the Interactome of Newly Transcribed RNA 4.22
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.22
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.19
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 4.17
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 4.17
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.16
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.15
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.12
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 4.11
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 4.09
CROP-Seq in Primary Human T Cells 4.05
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.02
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.02
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.01
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 4.0
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 3.98
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 3.98
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.97
The evolution of N6-methyladenosine in primates 3.97
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 3.93
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.93
IL-33 activates tumor stroma to promote intestinal polyposis 3.91
Identification of HOXB13 target genes responsive to BET inhibitors 3.88
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.87
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 3.86
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 3.82
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.82
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.81
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.81
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 3.8
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.77
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.74
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.73
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 3.72
Impact of dieldrin on transcription in Jurkat T cells 3.71
Single-cell analysis of adult human ovary using 10X genomics 3.66
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 3.66
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 3.66
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 3.66
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.64
R430: A potent inbibitor of DNA and RNA viruses 3.59
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 3.55
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.51
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 3.46
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.45
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.44
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.44
Copper Regulation of HIF-1 Transcription Activity 3.42
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.42
RNA-seq of cells with TET1 knockout 3.41
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.41
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.41
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.41
Universal alternative splicing of noncoding exons 3.39
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 3.36
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 3.34
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.34
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.31
TCF7L1 knockdown in pancreatic cancer 3.3
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.28
Gene expression in PANC1 cells treated with Rakicidin 3.25
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 3.24
Paxillin regulates genomic networks in prostate cancer [PC3] 3.22
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 3.2
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.17
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 3.16
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.16
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.14
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 3.12
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.09
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.05
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.05
Studying the selectivity of a small molecule Synucleozid on transcriptome 3.04
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.03
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.03
RNA-seq analysis of control and Myc-induced U2OS cells 3.02
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 3.0
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 3.0
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 2.99
Total RNA sequencing of WT intestinal orgaonids. 2.99
Comprehensive comparative analysis of 5’ end RNA sequencing methods 2.98
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 2.96
DRB/GRO-Seq -/+ UV 2.94
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.93
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.93
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.92
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.92
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 2.9
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.89
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.88
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 2.88
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 2.88
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.84
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.84
Transcriptome sequencing of K-562 cells 2.79
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 2.78
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 2.77
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 2.76
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 2.75
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 2.69
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 2.63
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 2.62
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.61
Genome-wide discovery of human splicing branchpoints [RNAse] 2.59
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.57
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.57
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.57
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.57
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 2.56
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 2.56
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 2.55
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 2.55
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 2.55
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.53
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.53
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.53
Gene expression signatures of innate lymphoid cells from human blood 2.51
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.5
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 2.49
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 2.48
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.46
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.45
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 2.45
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 2.44
RNA Seq of HMVEC under hypoxia 2.44
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.42
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.41
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.4
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.4
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 2.39
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.38
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 2.36
CD73 knockdown effect in pancreatic cancer cell lines 2.36
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 2.34
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.3
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 2.3
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 2.28
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.26
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.25
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.24
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 2.23
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 2.23
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 2.23
Effect of ILF3 on translation during homeostasis and the antiviral response 2.2
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 2.19
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 2.19
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.19
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.18
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 2.13
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.11
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 2.11
KSDM1b Role in Ewing Sarcoma 2.1
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 2.1
Regulation of hypoxia-inducible factor activity by ZMYND8 2.08
PRDM1 inhibits proliferation of human colon cancer organoids 2.07
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.05
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.05
Analysis of transcriptional regulation by Myt1 and Myt1l 2.02
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 2.0
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.0
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 1.99
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 1.99
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 1.99
snRNAs as regulators of alternative splicing 1.97
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.97
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 1.97
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.96
The MEF2B Regulatory Network - RNA-seq data 1.96
The MEF2B Regulatory Network 1.96
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.95
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.95
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.93
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.93
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.88
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 1.87
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 1.87
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.86
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 1.81
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.78
RNA splicing alteration on glioblastoma and normal neural stem cells 1.77
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 1.74
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 1.74
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.7
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 1.68
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 1.66
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 1.66
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.65
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.63
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.61
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.61
Cajal bodies are linked to genome conformation 1.61
Cajal bodies are linked to genome conformation [RNA-Seq] 1.61
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.6
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.6
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 1.6
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.59
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.57
X-Ray induced DNA-Hydroxymethylation changes 1.56
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.56
Gene expression profiling of leukemia cells following asparagine depletion 1.56
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.55
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.55
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.55
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.55
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.53
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.53
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.53
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.53
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.53
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.53
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 1.52
Identification of Sin3B regulated genes during quiescence 1.51
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.51
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.51
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.5
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.5
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.5
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.5
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.49
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.48
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 1.47
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 1.43
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  1.43
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.43
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.41
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.38
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 1.37
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 1.35
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 1.33
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 1.33
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.33
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.33
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.32
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.31
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.31
Effect of drugs on transcriptomic profiles 1.29
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.28
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.28
Gene expression profile in breast cancer cells 1.28
Functional significance of the HIV-1 Tat signature amino acid residues 1.25
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.24
Genome-wide discovery of human splicing branchpoints 1.23
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.23
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.22
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 1.17
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.16
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 1.15
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 1.15
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.15
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.15
The transcriptome effect of overexpressing EZH2 in MCF7 1.15
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.14
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.13
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.1
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.09
RNA editing in nascent RNA affects pre-mRNA splicing 1.08
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.07
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.06
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.06
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.05
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.05
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 1.05
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.04
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.02
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.02
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.99
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.99
H1609088 Human RNA-Sequencing 0.99
Transciptomic profiling of human fetal lung samples 0.99
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.96
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.96
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 0.94
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.94
RNA-seq analysis of differentiating human erythroblasts 0.94
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 0.93
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 0.93
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.9
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.88
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.84
SRSF1 role in cellular gene expression and splicing 0.82
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 0.8
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 0.8
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.8
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.75
Dermal endothelial cells of type 2 diabetic patients 0.75
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.75
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.75
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.74
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.71
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.7
Clinker: visualizing fusion genes detected in RNA-seq data 0.7
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.69
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.68
Expression profiling of converted and control dermal BJ fibroblasts 0.68
miRNAs affected by antagomiR-17 treatment 0.68
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.67
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.67
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.67
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.67
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.67
Expression analysis of the TAF1 syndrome 0.66
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.63
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.63
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.63
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 0.62
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.62
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.57
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 0.56
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.54
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.54
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.54
Disruption of GRIN2B impairs differentiation in human neurons 0.54
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.52
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.51
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.51
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.5
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.5
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.47
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.47
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.46
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.46
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.45
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.42
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.4
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.39
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.39
Exploring ILF2 regulatory genes by next-generation sequencing 0.38
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.37
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.37
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.37
Effects of transcription on genome - nuclear lamina interactions 0.36
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.36
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.35
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.35
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.35
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.35
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.35
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.35
Ribosomal protein RPL26 is the principal target of UFMylation 0.33
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 0.33
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.32
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.31
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.29
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.29
quanTIseq: quantifying immune contexture of human tumors 0.29
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.28
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.27
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.27
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.26
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.26
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.25
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.25
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.25
MCF-7 as a model for functional analysis of breast cancer risk variants 0.24
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 0.22
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.22
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.21
Enhancer activation during EGF response 0.2
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.2
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.2
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.2
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.2
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.17
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.17
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.17
Metabolism as an early predictor of DPSCs aging 0.16
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.16
Discovering human diabetes-risk gene function with genetics and physiological assays 0.15
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.15
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.15
The circadian transcriptional landscape in primary human mammary epithelial cells 0.14
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.12
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.12
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.12
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.1
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.1
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.1
CUREfast: Accelerating research with families 0.09
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.08
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.07
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.07
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.06
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.05
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.03
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.02
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.01
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.01
ChIP-seq and RNA-seq from human lymphoma cell lines 0.01
RNA-seq data from human lymphoma cell lines 0.01
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation